Not All High-THC Cannabis Extracts Are Equal for Cancer or Inflammation
Testing 25 high-THC cannabis extracts found wide variation in anti-cancer and anti-inflammatory effects, with specific terpenes like terpinene and p-cymene correlating with better outcomes.
Quick Facts
What This Study Found
Anti-cancer efficacy ranged from 66% to 92% growth inhibition across 25 extracts. For inflammation, some extracts reduced cytokine expression by over 5-fold while others doubled it. The terpene terpinene correlated with anti-cancer activity (P=0.002), and p-cymene and beta-myrcene correlated with anti-inflammatory effects.
Key Numbers
25 extracts tested; 66-92% cancer growth inhibition range; >5-fold inflammation reduction (best) to 2-fold increase (worst); terpinene P=0.002 for anti-cancer
How They Did This
In vitro testing of 25 high-THC cannabis extracts on squamous cell carcinoma (HCC1806) cells and TNF-alpha/IFN-gamma-induced inflammation in human lung fibroblasts (WI38). Chemical profiling of THC, CBD, CBG, CBN, and 20 terpenes with correlation analysis.
Why This Research Matters
This study demonstrates that the "entourage effect" is real and measurable: cannabis extracts with similar THC levels produce vastly different biological outcomes depending on their terpene profiles.
The Bigger Picture
Not all cannabis is created equal. The specific combination of terpenes may matter as much as the THC content for medicinal effects, supporting the move toward terpene-aware product labeling.
What This Study Doesn't Tell Us
In vitro study only. Cancer cell line results do not predict clinical outcomes. Correlation between terpenes and activity does not prove the terpenes are directly responsible.
Questions This Raises
- ?Would terpene-enriched extracts show enhanced anti-cancer effects in animal models?
- ?Could terpene profiles be used to predict which cannabis products are most anti-inflammatory versus pro-inflammatory?
Trust & Context
- Key Stat:
- 66% to 92% range in cancer growth inhibition across extracts
- Evidence Grade:
- In vitro study on cell lines with correlational terpene analysis. No animal or human data.
- Study Age:
- Published in 2022
- Original Title:
- Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.
- Published In:
- Molecules (Basel, Switzerland), 27(18) (2022)
- Authors:
- Li, Dongping(2), Ilnytskyy, Yaroslav, Ghasemi Gojani, Esmaeel, Kovalchuk, Olga, Kovalchuk, Igor
- Database ID:
- RTHC-04003
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Do all cannabis extracts fight cancer equally?
No. This study found cancer growth inhibition ranged from 66% to 92% across 25 high-THC extracts, and some extracts actually worsened inflammation rather than reducing it.
Which terpenes were linked to anti-cancer effects?
Terpinene showed the strongest correlation with anti-cancer activity (P=0.002). For anti-inflammatory effects, p-cymene and beta-myrcene were positively correlated, while camphor was negatively correlated.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04003APA
Li, Dongping; Ilnytskyy, Yaroslav; Ghasemi Gojani, Esmaeel; Kovalchuk, Olga; Kovalchuk, Igor. (2022). Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.. Molecules (Basel, Switzerland), 27(18). https://doi.org/10.3390/molecules27186057
MLA
Li, Dongping, et al. "Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.." Molecules (Basel, 2022. https://doi.org/10.3390/molecules27186057
RethinkTHC
RethinkTHC Research Database. "Analysis of Anti-Cancer and Anti-Inflammatory Properties of ..." RTHC-04003. Retrieved from https://rethinkthc.com/research/li-2022-analysis-of-anticancer-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.